Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Companies that pay dividends have been a reliable choice for investors seeking a passive and somewhat stable income.

SpringWorks' Gomekli wins FDA approval for NF1-related tumors, showing strong efficacy in trials. U.S. launch expected in two ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Crispr Therapeutics AG (CRSP – Research Report), Jazz ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Travere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.

MaxCyte (MXCT) announced they are entering into a strategic platform license with TG Therapeutics (TGTX). Under the terms of the agreement, TG ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Highlights,Jefferies Financial Group raises Compass Therapeutics' target price, reflecting an optimistic market view.,The ...

Here are the best tax software deals to shop at Amazon.

In the interconnected ASX healthcare sector it can be common for leaders to be involved in multiple companies and ...